Preparation of novel (-)-gossypol nanoparticles and the effect on growth inhibition in human prostate cancer PC-3 cells in vitro

Jin,Cai-Ling; Chen,Mei-Ling; Wang,Ying; Kang,Xiao-Chun; Han,Guang-Ye; Xu,Su-Ling

doi:10.3892/etm.2015.2172

March-2015 Volume 9 Issue 3

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

March-2015 Volume 9 Issue 3

Full Size Image

Article Open Access

Preparation of novel (-)-gossypol nanoparticles and the effect on growth inhibition in human prostate cancer PC-3 cells in vitro

Authors:
- Cai-Ling Jin
- Mei-Ling Chen
- Ying Wang
- Xiao-Chun Kang
- Guang-Ye Han
- Su-Ling Xu
View Affiliations / Copyright

Affiliations: Department of Oncology, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan 453100, P.R. China, Department of Urology, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan 453100, P.R. China

Copyright: © Jin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Pages: 675-678
|
Published online on: January 8, 2015

https://doi.org/10.3892/etm.2015.2172
Expand metrics +

Abstract

The aim of the present study was to investigate the antitumor effects and possible mechanism of (‑)‑gossypol nanoparticles, loaded with vv polyethylene glycol‑maleimide (mPEG‑Mal), in vitro. Emulsification‑volatilization was used to prepare the loaded (‑)‑gossypol nanoparticles. The toxicity of blank nanoparticles on human prostate cancer PC‑3 cells and human prostate RWPE‑1 cells was measured. The antitumor effects of the nanoparticles on PC‑3 cells were evaluated by an MTT assay, acridine orange staining and transmission electron microscopy in vitro, and the results were compared with those of free (‑)‑gossypol. In addition, the mRNA expression levels of Bcl‑2 and Bak were measured using semi‑quantitative reverse transcription polymerase chain reaction. The growth inhibition activity of the loaded (‑)‑gossypol nanoparticles was found to be dose‑ and time‑dependent, and similar to the activity of free (‑)‑gossypol. The nanoparticles induced apoptotic morphological changes on the PC‑3 cells, downregulating the mRNA expression level of Bcl‑2 and upregulating the mRNA expression level of Bak. Blank nanoparticles exhibited no evident toxicity on PC‑3 and RWPE‑1 cells at a high dose. Therefore, the mPEG‑Mal loaded (‑)‑gossypol nanoparticles demonstrated a favorable antitumor activity and no toxicity. The nanoparticles were able to induce the apoptosis of prostate cancer cells; thus, may be a potential antitumor nanodrug.

View Figures

View References

1	Keshmiri-Neghab H and Goliaei B: Therapeutic potential of gossypol: an overview. Pharm Biol. 52:124–128. 2014. View Article : Google Scholar
2	Wang X, Howell CP, Chen F, Yin J and Jiang Y: Gossypol - a polyphenolic compound from cotton plant. Adv Food Nutr Res. 58:215–263. 2009. View Article : Google Scholar
3	Lopez LM, Grimes DA and Schulz KF: Nonhormonal drugs for contraception in men: a systematic review. Obstet Gynecol Surv. 60:746–752. 2005. View Article : Google Scholar : PubMed/NCBI
4	Oliver CL, Bauer JA, Wolter KG, et al: In vitro effects of the BH3 mimetic, (-)-gossypol, on head and neck squamous cell carcinoma cells. Clin Cancer Res. 10:7757–7763. 2004. View Article : Google Scholar : PubMed/NCBI
5	Stein RC, Joseph AE, et al: A preliminary clinical study of gossypol in advanced human cancer. Cancer Chemother Pharmacol. 30:480–482. 1992. View Article : Google Scholar : PubMed/NCBI
6	Le Blanc M, Russo J, Kudelka AP and Smith JA: An in vitro study of inhibitory activity of gossypol, a cottonseed extract, in human carcinoma cell lines. Pharmacol Res. 46:551–555. 2002. View Article : Google Scholar : PubMed/NCBI
7	Kapoor S: Attenuating effect of gossypol on tumor growth in systemic malignancies. Cell Biochem Biophys. 67:1551–1552. 2013. View Article : Google Scholar : PubMed/NCBI
8	Oliver CL, Miranda MB, Shangary S, et al: (-)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-X(L)-mediated apoptosis resistance. Mol Cancer Ther. 4:23–31. 2005. View Article : Google Scholar : PubMed/NCBI
9	Meng Y, Tang W, Dai Y, et al: Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa. Mol Cancer Ther. 7:2192–2202. 2008. View Article : Google Scholar : PubMed/NCBI
10	Mohammad RM, Wang S, Aboukameel A, et al: Preclinical studies of a nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-X(L) [(-)-gossypol] against diffuse large cell lymphoma. Mol Cancer Ther. 4:13–21. 2005. View Article : Google Scholar : PubMed/NCBI
11	Wolter KG, Wang SJ, Henson BS, et al: (-)-Gossypol inhibits growth and promotes apoptosis of human head and neck squamous cell carcinoma in vivo. Neoplasia. 8:163–172. 2006. View Article : Google Scholar : PubMed/NCBI
12	Zhang XQ, Huang XF, Mu SJ, et al: Inhibition of proliferation of prostate cancer cell line, PC-3, in vitro and in vivo using (-)-gossypol. Asian J Androl. 12:390–399. 2010. View Article : Google Scholar : PubMed/NCBI
13	Wang WT, Huang XF, Mu SJ, et al: Study on the effects of (-)-gossypol in inducing apoptosis of human prostate cancer PC-3 cells in vitro. Xian Dai Zhong Liu Yi Xue. 12:251–254. 2011.(In Chinese).
14	Allen TM and Cullis PR: Drug delivery systems: entering the mainstream. Science. 303:1818–1822. 2004. View Article : Google Scholar : PubMed/NCBI
15	Zhang SX and Li QF: Application on nano-scale drug vehicles in cancer therapy. Zhong Hua Zhong Liu Fang Zhi Za Zhi. 17:1031–1034. 2010.(In Chinese).
16	Agarwal A, Saraf S, Asthana A, et al: Ligand based dendritic systems for tumor targeting. Int J Pharm. 350:3–13. 2008. View Article : Google Scholar
17	Gabizon AA: Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy. Cancer Invest. 19:424–436. 2001. View Article : Google Scholar : PubMed/NCBI
18	Kaza N, Kohli L, Graham CD, et al: BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells. PLoS One. 9:e967332014. View Article : Google Scholar
19	Chawla JS and Amiji MM: Biodegradable poly(epsilon-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm. 249:127–138. 2002. View Article : Google Scholar : PubMed/NCBI
20	Oyewumi MO, Yokel RA, Jay M, et al: Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice. J Control Release. 95:613–626. 2004. View Article : Google Scholar : PubMed/NCBI
21	Xu L, Wang G, Tang N, et al: 27th Annual The Charles A. Coltman, Jr. San Antonio Breast Cancer Symposium: Discovery and therapeutic potential of novel Bcl-2/Bcl-xL small-molecule inhibitors in human breast cancer. Breast Cancer Res Treat. 88(1 Suppl): S662004.